• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

格列本脲抑制 NLRP3 炎性小体减轻百草枯和代森锰诱导的小鼠帕金森病模型中的多巴胺能神经退行性变和运动缺陷。

Inhibition of NLRP3 inflammasome by glibenclamide attenuated dopaminergic neurodegeneration and motor deficits in paraquat and maneb-induced mouse Parkinson's disease model.

机构信息

Qingdao Municipal Center for Disease Control & Prevention, Qingdao Institute of Preventive Medicine, Qingdao, 266033, China; School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, 250012, China.

Department of Anesthesiology, Affiliated Zhongshan Hospital of Dalian University, Dalian, 116023, China.

出版信息

Toxicol Lett. 2021 Oct 1;349:1-11. doi: 10.1016/j.toxlet.2021.05.008. Epub 2021 May 27.

DOI:10.1016/j.toxlet.2021.05.008
PMID:34052309
Abstract

Pesticides exposure can lead to damage of dopaminergic neurons, which are associated with increased risk of Parkinson's disease (PD). However, the etiology of PD remains poorly understood and no therapeutic strategy is available. Previous studies suggested the involvement of NLRP3 inflammasome in the onset of PD. This study was designed to investigate whether glibenclamide, an inhibitor of NLRP3 inflammasome, could offer a reliable protective strategy for PD in a mouse PD model induced by paraquat and maneb. We found that glibenclamide exerted potent neuroprotection against paraquat and maneb-induced upregulation of α-synuclein, dopaminergic neurodegeneration and motor impairment in brain of mice. Mechanistically, glibenclamide treatment blocked NLRP3 inflammasome activation evidenced by reduced expressions of NLRP3, activated caspase-1 and mature interleukin-1β in glibenclamide co-treated mice compared with those in paraquat and maneb group mice. Furthermore, glibenclamide treatment mitigated paraquat and maneb-induced microglial M1 proinflammatory response and nuclear factor-κB activation in mice. Finally, the increased superoxide production, lipid peroxidation, protein levels of NADPH oxidase 2 (NOX2) and inducible nitric oxide synthase (iNOS) induced by paraquat and maneb were all attenuated by glibenclamide. Overall, our findings demonstrated that glibenclamide protected dopaminergic neurons in a mouse PD model induced by combined exposures of paraquat and maneb through suppression of NLRP3 inflammasome activation, microglial M1 polarization and oxidative stress.

摘要

农药暴露可导致多巴胺能神经元损伤,与帕金森病(PD)风险增加有关。然而,PD 的病因仍不清楚,也没有有效的治疗策略。先前的研究表明,NLRP3 炎性小体参与了 PD 的发病机制。本研究旨在探讨格列本脲(NLRP3 炎性小体抑制剂)是否能在百草枯和代森锰诱导的 PD 小鼠模型中为 PD 提供可靠的保护策略。我们发现,格列本脲对百草枯和代森锰诱导的α-突触核蛋白、多巴胺能神经退行性变和小鼠大脑运动功能障碍具有强大的神经保护作用。在机制上,与百草枯和代森锰组相比,格列本脲治疗组小鼠 NLRP3 炎性小体的激活受到抑制,NLRP3、活化的 caspase-1 和成熟的白细胞介素-1β的表达降低。此外,格列本脲治疗减轻了百草枯和代森锰诱导的小鼠小胶质细胞 M1 前炎性反应和核因子-κB 激活。最后,百草枯和代森锰诱导的超氧阴离子产生、脂质过氧化、NADPH 氧化酶 2(NOX2)和诱导型一氧化氮合酶(iNOS)的蛋白水平增加均被格列本脲减弱。总之,我们的研究结果表明,格列本脲通过抑制 NLRP3 炎性小体激活、小胶质细胞 M1 极化和氧化应激,保护百草枯和代森锰联合暴露诱导的 PD 小鼠模型中的多巴胺能神经元。

相似文献

1
Inhibition of NLRP3 inflammasome by glibenclamide attenuated dopaminergic neurodegeneration and motor deficits in paraquat and maneb-induced mouse Parkinson's disease model.格列本脲抑制 NLRP3 炎性小体减轻百草枯和代森锰诱导的小鼠帕金森病模型中的多巴胺能神经退行性变和运动缺陷。
Toxicol Lett. 2021 Oct 1;349:1-11. doi: 10.1016/j.toxlet.2021.05.008. Epub 2021 May 27.
2
Integrin CD11b mediates locus coeruleus noradrenergic neurodegeneration in a mouse Parkinson's disease model.整合素 CD11b 介导小鼠帕金森病模型蓝斑去甲肾上腺素能神经元退行性变。
J Neuroinflammation. 2020 May 6;17(1):148. doi: 10.1186/s12974-020-01823-3.
3
Integrin Mac1 mediates paraquat and maneb-induced learning and memory impairments in mice through NADPH oxidase-NLRP3 inflammasome axis-dependent microglial activation.整合素 Mac1 通过 NADPH 氧化酶-NLRP3 炎性小体轴依赖性小胶质细胞激活介导百草枯和代森锰诱导的小鼠学习记忆损伤。
J Neuroinflammation. 2023 Feb 18;20(1):42. doi: 10.1186/s12974-023-02732-x.
4
Taurine protects dopaminergic neurons in a mouse Parkinson's disease model through inhibition of microglial M1 polarization.牛磺酸通过抑制小胶质细胞 M1 极化来保护帕金森病模型中的多巴胺能神经元。
Cell Death Dis. 2018 Apr 1;9(4):435. doi: 10.1038/s41419-018-0468-2.
5
Inhibition of NADPH oxidase by apocynin prevents learning and memory deficits in a mouse Parkinson's disease model.阿朴肉桂酸抑制烟酰胺腺嘌呤二核苷酸磷酸氧化酶可预防帕金森病模型小鼠的学习记忆障碍。
Redox Biol. 2019 Apr;22:101134. doi: 10.1016/j.redox.2019.101134. Epub 2019 Feb 8.
6
FTY720 Inhibits MPP-Induced Microglial Activation by Affecting NLRP3 Inflammasome Activation.FTY720 通过影响 NLRP3 炎性小体激活抑制 MPP+诱导的小胶质细胞激活。
J Neuroimmune Pharmacol. 2019 Sep;14(3):478-492. doi: 10.1007/s11481-019-09843-4. Epub 2019 May 8.
7
Poloxamer 188-mediated anti-inflammatory effect rescues cognitive deficits in paraquat and maneb-induced mouse model of Parkinson's disease.泊洛沙姆 188 介导的抗炎作用可挽救百草枯和代森锰诱导的帕金森病小鼠模型中的认知缺陷。
Toxicology. 2020 Apr 30;436:152437. doi: 10.1016/j.tox.2020.152437. Epub 2020 Mar 10.
8
Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice.炎症小体抑制可预防小鼠 α-突触核蛋白病和多巴胺能神经退行性变。
Sci Transl Med. 2018 Oct 31;10(465). doi: 10.1126/scitranslmed.aah4066.
9
Glibenclamide attenuates 2,5-hexanedione-induced neurotoxicity in the spinal cord of rats through mitigation of NLRP3 inflammasome activation, neuroinflammation and oxidative stress.格列本脲通过减轻 NLRP3 炎性小体激活、神经炎症和氧化应激减轻 2,5-己二酮诱导的大鼠脊髓神经毒性。
Toxicol Lett. 2020 Oct 1;331:152-158. doi: 10.1016/j.toxlet.2020.06.002. Epub 2020 Jun 6.
10
Paraquat and maneb co-exposure induces noradrenergic locus coeruleus neurodegeneration through NADPH oxidase-mediated microglial activation.百草枯和代森锰锌共同暴露通过NADPH氧化酶介导的小胶质细胞激活诱导去甲肾上腺素能蓝斑核神经变性。
Toxicology. 2017 Apr 1;380:1-10. doi: 10.1016/j.tox.2017.02.009. Epub 2017 Feb 13.

引用本文的文献

1
Sulphonylureas as Adjunct Therapeutic Agents in the Treatment of Autoimmune Conditions: A Narrative Review.磺酰脲类作为自身免疫性疾病治疗的辅助治疗药物:一项叙述性综述。
Pharmacol Res Perspect. 2025 Aug;13(4):e70155. doi: 10.1002/prp2.70155.
2
IC100 blocks inflammasome activation induced by α-synuclein aggregates and ASC specks.IC100可阻断由α-突触核蛋白聚集体和ASC斑点诱导的炎性小体激活。
NPJ Parkinsons Dis. 2025 Apr 25;11(1):92. doi: 10.1038/s41531-025-00963-8.
3
Exploring the therapeutic potential of NLRP3 inhibitors in Parkinson's Disease: a systematic review of in-vivo studies.
探索NLRP3抑制剂在帕金森病中的治疗潜力:一项体内研究的系统综述
Inflammopharmacology. 2025 Apr 21. doi: 10.1007/s10787-025-01733-x.
4
Inactivation of NLRP3 inflammasome by dephosphorylation at Serine 658 alleviates glial inflammation in the mouse model of Parkinson's disease.丝氨酸658位点去磷酸化使NLRP3炎性小体失活,减轻帕金森病小鼠模型中的神经胶质炎症。
Mol Neurodegener. 2025 Mar 5;20(1):27. doi: 10.1186/s13024-025-00818-z.
5
Tim-3 Deficiency Ameliorates Motor Deficits and Neuroinflammation in MPP+/MPTP-Induced Parkinson's Disease Models via the NF-κB/NLRP3 Pathway.Tim-3缺陷通过NF-κB/NLRP3途径改善MPP+/MPTP诱导的帕金森病模型中的运动功能障碍和神经炎症。
Mol Neurobiol. 2025 May;62(5):5566-5578. doi: 10.1007/s12035-024-04560-3. Epub 2024 Nov 23.
6
Antidiabetic drugs in Parkinson's disease.帕金森病中的抗糖尿病药物。
Clin Park Relat Disord. 2024 Jul 18;11:100265. doi: 10.1016/j.prdoa.2024.100265. eCollection 2024.
7
Palmatine Ameliorates Motor Deficits and Dopaminergic Neuron Loss by Regulating NLRP3 Inflammasome through Mitophagy in Parkinson's Disease Model Mice.在帕金森病模型小鼠中,巴马汀通过线粒体自噬调节NLRP3炎性小体改善运动功能障碍和多巴胺能神经元损失。
Mol Neurobiol. 2025 Feb;62(2):2250-2263. doi: 10.1007/s12035-024-04367-2. Epub 2024 Aug 3.
8
Mechanisms Mediating the Combined Toxicity of Paraquat and Maneb in SH-SY5Y Neuroblastoma Cells.介导百草枯和代森锰联合毒性在 SH-SY5Y 神经母细胞瘤细胞中的机制。
Chem Res Toxicol. 2024 Aug 19;37(8):1269-1282. doi: 10.1021/acs.chemrestox.3c00389. Epub 2024 Jul 26.
9
Targeting NLRP3 Inflammasomes: A Trojan Horse Strategy for Intervention in Neurological Disorders.靶向NLRP3炎性小体:一种干预神经疾病的木马策略。
Mol Neurobiol. 2025 Feb;62(2):1840-1881. doi: 10.1007/s12035-024-04359-2. Epub 2024 Jul 23.
10
Role of NLRP3 inflammasome in central nervous system diseases.NLRP3炎性小体在中枢神经系统疾病中的作用。
Cell Biosci. 2024 Jun 7;14(1):75. doi: 10.1186/s13578-024-01256-y.